Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Cronos Group

Tilray Brands

The fascinating world of cannabis! In recent years, this exciting sector has attracted the interest of investors and consumers alike.

3 Cannabis Stocks to Buy Before the Breakout

Canopy Growth's revenue growth has turned negative. The situation isn't improving, and that's putting pressure on other areas of its financials.

Canopy Growth's Struggles in 4 Charts

SMITHS FALLS, ON , July 26, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter fiscal year 2024 ended June 30, 2023 after markets close on August 9, 2023. Following the release of its first quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on August 9, at 5:30 PM Eastern Time.

Canopy Growth to Report First Quarter Fiscal 2024 Financial Results on August 9, 2023

Strong demand for legal cannabis products in the Canadian recreational cannabis market and the launch of new products are expected to have driven Canopy Growth's (CGC) Q1 performance.

What's in Store for Canopy Growth (CGC) in Q1 Earnings?

Aurora Cannabis

Neptune Wellness Solutions Inc.

Looking for the best marijuana stocks to buy in 2023? It's crucial to consider the risks associated with the cannabis industry. For example things like regulatory uncertainties, legal changes, and market volatility. As well as operational challenges. Also stay updated with industry news, tracking relevant sources, and monitoring regulatory updates.

3 Canadian Marijuana Stocks To Watch Today 2023

NEW YORK , July 24, 2023 /PRNewswire/ -- Attention Canopy Growth Corporation ("Canopy Growth") (NASDAQ: CGC) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between June 1, 2021 and May 10, 2023. If you suffered a loss on your investment in Canopy Growth, contact us about potential recovery by using the link below.

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Canopy Growth Investors of a Lead Plaintiff Deadline of July 24, 2023

NEW YORK , July 22, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between June 1, 2021 and May 10, 2023, both dates inclusive (the "Class Period"), of the important July 24, 2023 lead plaintiff deadline. SO WHAT: If you purchased Canopy Growth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

CGC MONDAY DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important July 24 Deadline in Securities Class Action - CGC

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 24, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Canopy Growth Corporation (“Canopy Growth” or the “Company”) (NASDAQ: CGC) securities between May 31, 2022 and May 10, 2023, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On May 10, 2023, after the market closed, Canopy Growth.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Canopy Growth Corporation (CGC)

NEW YORK , July 21, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Canopy Growth Corporation (NASDAQ: CGC). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/canopy-growth-class-action-loss-submission-form/?id=42374&from=4 The lawsuit seeks to recover losses for shareholders who purchased Canopy Growth between June 1, 2021 and May 10, 2023.

CGC SHAREHOLDER ALERT: Jakubowitz Law Reminds Canopy Growth Shareholders of a Lead Plaintiff Deadline of July 24, 2023

BENSALEM, Pa. , July 20, 2023 /PRNewswire/ -- Law Offices of Howard G.

CGC Investors Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit

Certification reinforces STORZ & BICKEL's leadership position in medical device design, ensures continued availability of devices worldwide TUTTLINGEN, Germany , July 20, 2023 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), the world-leading manufacturer of high-end and medically certified cannabis vaporizers and subsidiary of Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC), today announced the certification of its premium VOLCANO MEDIC 2 and the MIGHTY+ MEDIC, in accordance with the new EU Medical Device Regulations ("MDR"). The new MDR regulations outline stricter quality requirements for medical devices manufactured in or imported to the EU than its predecessor, the MDD (Medical Devices Directive).

STORZ & BICKEL Announces Certification of Medical Vaporizers Under New EU Medical Device Regulations

NEW YORK , July 20, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Canopy Growth Corporation ("Canopy Growth" or the "Company") (NASDAQ: CGC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Canopy Growth investors who were adversely affected by alleged securities fraud between June 1, 2021 and May 10, 2023.

CGC LAWSUIT ALERT: Levi & Korsinsky Notifies Canopy Growth Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Village Farms International

As the Canadian cannabis sector grows, investors and traders keep close tabs on the market for prospective possibilities. July 2023 is a very interesting month for Canadian cannabis stocks, with several significant events and developing trends on the horizon.

Top Canadian Cannabis Stocks Under $1 to Watch in July 2023: Affordable Investments with High Growth Potential

NEW YORK , July 19, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Canopy Growth Corporation. Shareholders who purchased shares of CGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Canopy Growth Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 24, 2023 - (NASDAQ: CGC)

Wana Brands re-enters the Florida medical market as Jetty expands to Colorado SMITHS FALLS, ON , July 18, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today congratulates members of Canopy USA LLC's ("Canopy USA") ecosystem, Wana Brands ("Wana"), North America's leading edibles producer, and Jetty Extracts ("Jetty"), a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology, on their respective asset-light expansion strategies which have seen the brands enter two new state-level markets. "Wana and Jetty are category leaders in edibles and solventless vape and we're proud of their ongoing expansion to deliver high quality products to consumers across two new states," said David Klein, CEO, Canopy Growth.

Canopy Growth Congratulates Wana and Jetty on Entry Into New State-Level Markets

NEW YORK , July 18, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Canopy Growth Corporation (NASDAQ: CGC) alleging that the Company violated federal securities laws. Class Period: June 1, 2021 to May 10, 2023 Lead Plaintiff Deadline: July 24, 2023 No obligation or cost to you.

CGC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 24, 2023 in the Class Action Filed on Behalf of Canopy Growth Corporation Shareholders

NEW YORK , July 17, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Canopy Growth Corporation ("Canopy Growth" or the "Company") (NASDAQ: CGC), and certain officers.   The class action, filed in the United States District Court for the Central District of California, and docketed under 23-cv-04905, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Canopy Growth securities between June 1, 2021 and May 10, 2023, inclusive (the "Class Period").

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Canopy Growth Corporation of Class Action Lawsuit and Upcoming Deadline - CGC

LOS ANGELES, CA / ACCESSWIRE / July 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Canopy Growth Corporation ("Canopy Growth" or "the Company") (NASDAQ:CGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 1, 2021 and May 10, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before July 24, 2023.

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Canopy Growth Corporation with Losses of $500,000 to Contact the Firm

NEW YORK , July 15, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between June 1, 2021 and May 10, 2023, both dates inclusive (the "Class Period"), of the important July 24, 2023 lead plaintiff deadline. SO WHAT: If you purchased Canopy Growth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important July 24 Deadline in Securities Class Action - CGC

The town of Smiths Falls, Ont., cheered when Canopy Growth Corp. and its Tweed brand closed a purchase in 2017 of a famed Hershey chocolate plant that had sat vacant for years.

Once-mighty Canopy Growth loses billions as dream of pot riches runs into reality of oversupply and overspending

Canopy Growth Corp. CGC, -39.60% said Friday it received written notice from the Nasdaq Stock Market listing qualification department that it is not in compliance with the exchange's listing rules. Canopy Growth said it received notice from the Nasdaq on July 11 that its stock has been below $1.00 per share for 30 consecutive business days.

Canopy Growth's stock slides below $1, triggering delisting notice

Canopy Growth Corp shares sank 32% to C$0.58 in early Friday trading after the Canadian cannabis company said it has entered into redemption agreements with lenders to reduce its debt, which would involve paying cash and converting notes into about 90.4 million Canopy Growth shares. Canopy noted the move is expected reduce its corporate debt by about $437 million over the next two quarters, and lower its annual interest costs by between $20 million and $30 million.

Canopy Growth stock drops on debt reduction deal

Canopy Growth Corp. CGC, +15.37% WEED, +14.86% said Friday it has reached agreements with its lenders that will delever its balance sheet by $437 million over the next six months. The agreements will also help it reduce annual interest costs by $20 million to $30 million.

Canopy Growth strikes agreements with lenders to delever its balance sheet by $437 million over next six months

Company Announces Accretive Reduction of Corporate Debt, Preservation of Cash, and an Improved Financial Position Through a Series of Agreements Supported by Secured and Unsecured Lenders SMITHS FALLS, ON , July 14, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that it has entered into a series of agreements,  including privately negotiated redemption agreements (the "Redemption Agreements") with certain holders of its unsecured senior notes due July 15, 2023 (the "Existing Notes") and agreements with certain of its lenders under its term loan credit agreement dated March 18, 2021 (the "Credit Agreement"), that will have the overall effect of deleveraging the Company's balance sheet. Highlights Total Debt Reduction: ~ $437 1 million expected over the next 2 quarters Annualized Interest Expense Savings: ~ $20 – $30 million Discount Capture: Repayment of principal owing under the Credit Agreement between 93% and 95% of par Elimination of Call Premium: Ability to prepay remainder of loan at par Enhanced Equity Capitalization: Conversion of ~ 41% of Existing Notes into Common Shares As a result of the agreements with our secured and unsecured lenders, the Company is expected to reduce its total debt by approximately $437 million over the next 6 months and lower annual interest costs by approximately $20 to $30 million.

Canopy Growth Enhances Financial Flexibility and Delivers Company Balance Sheet by $437 million

Canopy Growth recently told investors it might struggle to pay its debts. The marijuana seller has been depleting its current assets over the past four years.

News for Canopy Growth Stock (CGC)